No Data
No Data
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Express News | Aclaris Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Aclaris Therapeutics And 2 Other US Penny Stocks To Watch
Cantor Fitzgerald Upgrades Aclaris Therapeutics to Overweight
Cantor Fitzgerald Upgrades Aclaris Therapeutics(ACRS.US) to Buy Rating